AI model aims to forecast cancer survival and treatment success
NCT ID NCT07354295
Summary
This study is testing an artificial intelligence (AI) tool designed to predict how patients with esophageal cancer will respond to treatment and their likely survival. The AI analyzes various types of patient data, including medical scans and tissue samples, to find patterns. The goal is to help doctors better understand a patient's prognosis and potentially guide treatment decisions, but this is a prediction tool, not a treatment itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji hospital, Tongji medical college, Huazhong university of science and technology
RECRUITINGWuhan, Other (Non U.s.), 430030, China
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.